Combined immunohistochemistry β-catenin, cytokeratin 7, and cytokeratin 20 is useful in discriminating primary lung adenocarcinomas from metastatic colorectal cancer

BMC Cancer

Volumn 6, Issue , 2006, Pages

  Ikeda, Satoshi ^a   Fujimori, Masahiko ^b   Shibata, Satoshi ^b   Okajima, Masazumi ^a   Ishizaki, Yasuyo ^b   Kurihara, Takeshi ^b   Miyata, Yoshihiro ^b   Iseki, Masahiko ^b   Shimizu, Yosuke ^b   Tokumoto, Noriaki ^b   Ozaki, Shinji ^b   Asahara, Toshimasa ^b  

^a HIROSHIMA UNIVERSITY   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BETA CATENIN; CYTOKERATIN 20; CYTOKERATIN 7; CTNNB1 PROTEIN, HUMAN; KERATIN; KRT20 PROTEIN, HUMAN; KRT7 PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LUNG METASTASIS; ADENOCARCINOMA; COLORECTAL TUMOR; GENE EXPRESSION PROFILING; LUNG TUMOR; METASTASIS; PATHOLOGY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

ADENOCARCINOMA; BETA CATENIN; COLORECTAL NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-20; KERATIN-7; KERATINS; LUNG NEOPLASMS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 33144478129     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-6-31     Document Type: Article

References (32)

1. Kikuchi A: Regulation of β-catenin signaling in the Wnt path-way. Biochem Biophys Res Commun 2000, 268(2):243-248.
2. Kikuchi A: Tumor formation by genetic mutations in the components of the Wnt signaling pathway. Cancer Sci 2003, 94(3):225-229.
3. Dale TC: Signal transduction by the Wnt family of ligands. Biochem J 1998, 329(Pt 2):209-223.
4. Tetsu O, McCormick F: β-Catenin regulates expression of cyclin DI in colon carcinoma cells. Nature 1999, 398(6726):422-426.
5. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzier KW: ldentification of c-MYC as a target of the APC pathway. Science 1998, 281(5382):1509-1512.
6. Miyoshi Y, Ando H, Nagase H, Nishisho I, Horii A, Miki Y, Mori T, Utsunomiya J, Baba S, Petersen G, Hamilton SR, Kinzler KW ' Vogelstein B, Nakamura Y: Germ-line mutations of the APC gene in 53 familial adenomatous polyposis patients. Proc Natl Acad Sci USA 1992, 89(10):4452-4456.
7. Powell SM, Zilz N, Beazer-Barclay Y, Bryan TM, Hamilton SR, Thibodeau SN, Vogelstein B, Kinzler KW: APC mutations occur early during colorectal tumorigenesis. Nature 1992, 359(6392):235-237.
8. Shimizu Y, Ikeda S, Fujimori M, Kodama S, Nakahara M, Okajima M, Asahara T: Frequent alterations in the Wnt signaling pathway in colorectal cancer with microsatellite instability. Genes Chromosomes Cancer 2002, 33(1):73-81.
9. Albers KM: Keratin biochemistry. Clin Dermatol 1996, 14(4):309-320.
10. Chu PG, Weiss LM: Keratin expression in human tissues and neoplasms. Histopothology 2002, 40(5).403-439.
11. Travis WD, Colby TV, Corrin B: Histological typing of lung and pleural tumors. Berlin: Springer-Verlag; 1999.
12. Fujimori M, Ikeda S, Shimizu Y, Okajima M, Asahara T: Accumulation of β-catenin protein and mutations in exon 3 of β-catenin gene in gastrointestinal carcinoid tumor. Cancer Res 2001, 61(18):6656-6659.
13. Gumbiner BM: Signal transduction of β-catenin. Curr Opin Cell Biol 1995, 7(5):634-640.
14. Kinzler KW, Vogelstein B: Lessons from hereditary colorectal cancer. Cell 1996, 87(2):159-170.
15. Hugh TJ, Dillon SA, O'Dowd G, Getty B, Pignatelli M, Poston GJ, Kinsella AR: beta-catenin expression in primary and metastatic colorectal carcinoma. Int J Cancer 1999, 82(4):504-511.
16. Resnick MB, Routhier J, Konkin T, Sabo E, Pricolo VE: Epidermal growth factor receptor, c-MET, beta-catenin, and p53 expression as prognostic indicators in stage II colon cancer: a tissue microarray study. Clin Cancer Res 2004, 10(9):3069-3075.
17. Cooper CA, Bubb VJ, Smithson N, Carter RL, Gledhill S, Lamb D, Wyllie AH, Carey FA: Loss of heterozygosity at 5q21 in nonsmall cell lung cancer: a frequent event but without evidence of apc mutation. J Pathol 1996, 180(1):33-37.
18. Wada M, Miller CW, Yokota J, Lee E, Mizoguchi H, Koeffler HP: Molecular analysis of the adenomatous polyposis coli gene in sarcomas, hematological malignancies and noncolonic, neoplastic tissues. J Mol Med 1997, 75(2):139-144.
19. Brabender J, Usadel H. Danenberg KD, Metzger R, Schneider PM, Lord RV, Wickramasinghe K, Lum CE, Park J, Salonga D, Singer J, Sidransky D, Holscher AH, Meltzer SJ, Danenberg PV: Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival. Oncogene 2001, 20(27):3528-3532.
20. Virmani AK, Rathi A, Sathyanarayana UG, Padar A, Huang CX, Cunnigham HT, Farinas AJ, Milchgrub S, Euhus DM, Gilcrease M, Herman J, Minna JD, Gazdar AF: Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter IA in breast and lung carcinomas. Clin Cancer Res 2001, 7(7):1998-2004.
21. Pirinen RT, Hirvikoski P, Johansson RT, Hollmen S, Kosma VM: Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer. J Clin Pathol 2001, 54(5):391-395.
22. Rubin BP, Skarin AT, Pisick E, Rizk M, Salgia R: Use of cytokeratins 7 and 20 in determining the origin of metastatic carcinoma of unknown primary, with special emphasis on lung cancer. Eur J Cancer Prev 2001, 10(1):77-82.
23. Tot T: Cytokeratins 20 and 7 as biomarkers: usefulness in discriminating primary from metastatic adenocarcinoma. Eur J Cancer 2002, 38(6):758-763.
24. Kummar S, Fogarasi M, Canova A, Mota A. Ciesielski T: Cytokeratin 7 and 20 staining for the diagnosis of lung and colorectal adenocarcinoma. Br J Cancer 2002, 86(12):1884-1887.
25. Scarpatetti M. Tsybrovskyy O, Popper HH: Cytokeratin typing as an aid in the differential diagnosis of primary versus metastatic lung carcinomas, and comparison with normal lung. Virchows Arch 2002, 440(1):70-76.
26. Chu P, Wu E, Weiss LM: Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol 2000, 13 (9):962-972.
27. Wang HL, Lu DW, Yerian LM, Alsikafi N, Steinberg G, Hart J, Yang XJ: lmmunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Am J Surg Pathol 2001, 25(11):1380-1387.
28. Johansson L: Histopathologic classification of lung cancer: Relevance of cytokeratin and TTF-I immunophenotyping. Ann Diagn Pathol 2004, 8(5):259-267.
29. Jerome Marson V, Mazieres J, Groussard O, Garcia O, Berjaud J, Dahan M, Carles P, Daste G: Expression of TTF-I and cytokeratins in primary and secondary epithelial lung tumours: correlation with histological type and grade. Histopathology 2004, 45(2):125-134.
30. Moldvay J, Jackel M, Bogos K, Soltesz I, Agocs L, Kovacs G, Schaff Z: The role of TTF-I in differentiating primary and metastatic lung adenocarcinomas. Pathol Oncol Res 2004, 10(2):85-88.
31. Yatabe Y, Mitsudomi T, Takahashi T: TTF-I expression in pulmonary adenocarcinomas. Am J Surg Pathol 2002, 26(6):767-773.
32. Saad RS, Cho P, Silverman JF, Liu Y: Usefulness of Cdx2 in separating mucinous; bronchioloalveolar adenocarcinoma of the lung from metastatic mucinous colorectal adenocarcinoma. Am J Clin Pathol 2004, 122(3):421-427.